Qi Shu
Guangdong University of Technology(CN)Tibet University(CN)East China University of Science and Technology(CN)Chinese Academy of Sciences(CN)Wuhan University(CN)Zhejiang Cancer Hospital(CN)National Center for Nanoscience and Technology(CN)University of Chinese Academy of Sciences(CN)Hangzhou Cancer Hospital(CN)Jiangxi University of Finance and Economics(CN)Academia Sinica(TW)
Publications by Year
Research Areas
Manufacturing Process and Optimization, Immune cells in cancer, Cancer-related molecular mechanisms research, Industrial Technology and Control Systems, MicroRNA in disease regulation
Most-Cited Works
- → A novel risk model based on cuproptosis-related lncRNAs predicted prognosis and indicated immune microenvironment landscape of patients with cutaneous melanoma(2022)43 cited
- → miR-204 Regulates Cell Proliferation and Invasion by Targeting EphB2 in Human Cervical Cancer(2017)39 cited
- → Identification and experimental validation of mitochondria-related genes biomarkers associated with immune infiltration for sepsis(2023)36 cited
- → Ferroptosis: A novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity(2024)24 cited
- → Accumulation of Intracellular Ferrous Iron in Inflammatory-Activated Macrophages(2022)21 cited
- → Luteolin attenuated cisplatin-induced cardiac dysfunction and oxidative stress via modulation of Keap1/Nrf2 signaling pathway(2022)